S2Medical AB (publ) (FRA:S21)
Germany flag Germany · Delayed Price · Currency is EUR
0.0002
0.00 (0.00%)
At close: Dec 5, 2025

S2Medical AB Company Description

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden.

The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.

It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications.

In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge.

The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

S2Medical AB (publ)
Country Sweden
Founded 2013
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees 7
CEO Petter Sivler

Contact Details

Address:
Sunnorpsgatan 5
Linköping, 582 73
Sweden
Phone 46 87 00 00 50
Website s2m.se

Stock Details

Ticker Symbol S21
Exchange Frankfurt Stock Exchange
Share Class Class B Shares
Fiscal Year January - December
Reporting Currency SEK
SIC Code 3842

Key Executives

Name Position
Petter Sivler Chief Executive Officer
Marten Skog Chief Operating Officer